Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.477
|
Successful |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Fasted Clinical Chemistry / Glycerol
|
HET
|
9f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.845
|
Successful |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Fasted Clinical Chemistry / HDL-cholesterol
|
HET
|
9f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.0294
|
Successful |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Simplified IPGTT / Blood glucose concentration
|
HET
|
45f:45m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Fasted Clinical Chemistry / Free fatty acids
|
HET
|
9f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.538
|
Successful |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Fasted Clinical Chemistry / Triglycerides
|
HET
|
9f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.917
|
Successful |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Fasted Clinical Chemistry / Total cholesterol
|
HET
|
9f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.00547
|
Successful |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Fasted Clinical Chemistry / Glucose
|
HET
|
9f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.0895
|
Successful |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00386
|
Successful |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Fructosamine
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Fructosamine
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0826
|
Successful |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Glucose
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Glucose
|
HET
|
1f:m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Glucose
|
HET
|
f:1m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Glucose
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.718
|
Successful |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.733
|
Successful |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Urea
|
HET
|
f:1m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Urea
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Urea
|
HET
|
1f:m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Urea
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.870
|
Successful |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Creatinine
|
HET
|
f:1m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Creatinine
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Creatinine
|
HET
|
1f:m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Creatinine
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.538
|
Successful |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Sodium
|
HET
|
1f:m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Sodium
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Sodium
|
HET
|
f:1m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Sodium
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.164
|
Successful |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.687
|
Successful |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Potassium
|
HET
|
f:1m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Potassium
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.140
|
Successful |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0877
|
Successful |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0756
|
Successful |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0500
|
Successful |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HOM
|
2f:m
|
|
|
NotProcessed |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.276
|
Successful |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0322
|
Successful |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.279
|
Successful |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.148
|
Successful |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total bilirubin
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total bilirubin
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.612
|
Successful |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.732
|
Successful |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
DEXA / Fat/Body weight
|
HET
|
9f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.321
|
Successful |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
DEXA / Fat mass
|
HET
|
9f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.332
|
Successful |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Total cholesterol
|
HET
|
f:1m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Total cholesterol
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Total cholesterol
|
HET
|
1f:m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Total cholesterol
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00378
|
Successful |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Calorimetry / Carbon dioxide production
|
HET
|
f:1080m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Calorimetry / Oxygen consumption
|
HET
|
f:1080m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Triglyceride
|
HET
|
f:1m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Triglyceride
|
HET
|
1f:m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Triglyceride
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Triglyceride
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00469
|
Successful |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.872
|
Successful |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Calorimetry / Heat production (metabolic rate)
|
HET
|
f:540m
|
|
|
NotProcessed |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.418
|
Successful |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Dysmorphology / fat distribution
|
HET
|
9f:9m
|
|
|
NotProcessed |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HET
|
8f:8m
|
|
|
NotProcessed |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Creatine kinase
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Creatine kinase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.429
|
Successful |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0707
|
Successful |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.384
|
Successful |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Body Composition (DEXA lean/fat) / Fat mass
|
HOM
|
2f:m
|
|
|
NotProcessed |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Body Composition (DEXA lean/fat) / Fat mass
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.117
|
Successful |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.316
|
Successful |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Chloride
|
HET
|
f:1m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Chloride
|
HET
|
1f:m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Chloride
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Chloride
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.387
|
Successful |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Total protein
|
HET
|
f:1m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Total protein
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Total protein
|
HET
|
1f:m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Total protein
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.275
|
Successful |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / HDL-cholesterol
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0204
|
Successful |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Albumin
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Albumin
|
HET
|
f:1m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Albumin
|
HET
|
1f:m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Albumin
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.909
|
Successful |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Calcium
|
HET
|
f:1m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Calcium
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Calcium
|
HET
|
1f:m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Calcium
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.416
|
Successful |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HET
|
8f:8m
|
|
|
NotProcessed |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HOM
|
10f:5m
|
|
|
NotProcessed |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HET
|
40f:40m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Phosphorus
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Phosphorus
|
HET
|
f:1m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Phosphorus
|
HET
|
1f:m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Phosphorus
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
5.20×10-05
|
Successful |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Iron
|
HET
|
f:1m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Iron
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00376
|
Successful |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Lactate dehydrogenase
|
HET
|
f:1m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Lactate dehydrogenase
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0162
|
Successful |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
f:1m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.000231
|
Successful |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
f:1m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
1f:m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.275
|
Successful |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
f:1m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
4.35×10-05
|
Successful |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Alpha-amylase
|
HET
|
1f:m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Alpha-amylase
|
HET
|
2f:1m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Alpha-amylase
|
HET
|
f:1m
|
|
|
NotProcessed |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Alpha-amylase
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.230
|
Successful |
Ube2btm1a(EUCOMM)Wtsi
|
ICS
|
Simplified IPGTT / Glucose response AUC
|
HET
|
9f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.00132
|
Successful |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Triglycerides
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Triglycerides
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.239
|
Successful |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ube2btm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0504
|
Successful |